“In Silico Design, Molecular Docking, Molecular Dynamics Simulation, and ADMET Evaluation of Novel Quinazoline Derivatives as EGFR Inhibitors for Non-Small-Cell Lung Cancer” (2026) Annual Methodological Archive Research Review, 4(6), pp. 26–71. doi:10.5281/zenodo.21820790.